MedTrace Logo

EValuation of the Antioxidant and Anti-inflammatory Capacity of Nutraceutical IMMU·SYSTEM Food Supplement (EVAANIS)

NCT04912947 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-06-04

No results posted yet for this study

Summary

The aim of the study is to verify the effectiveness of Nutraceutical IMMU·SYSTEM Dietary supplement in reducing the levels of oxidative stress and inflammation in a sample of healthy adult subjects with high baseline levels of oxidative stress.

Conditions

  • Oxidative Stress

Interventions

DIETARY_SUPPLEMENT

Immusystem

Dietary supplement containing: Piceid, Glycine, Glutamine, Acetylcysteine, Zinc and Vitamin B6

OTHER

Placebo

Maltodextrin placebo capsule

Sponsors & Collaborators

  • Macrofarm Srl

    collaborator INDUSTRY

  • Icim International Srl

    collaborator UNKNOWN

  • Complife Italia Srl

    lead INDUSTRY

Principal Investigators

  • Francesco Puoci, PhD · DFSSN - UNICAL

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-30
Primary Completion
2021-04-15
Completion
2021-04-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04912947 on ClinicalTrials.gov